Deborah Bilder,
MD
Languages Spoken: English, German
Dr. Deborah Bilder is Medical Director of the Neurobehavior HOME Program. In this setting, she provides medical and psychiatric services in a novel medical home program in Salt Lake City, Utah, which serves individuals throughout the lifespan with developmental disabilities. Dr. Bilder also provides psychiatric consultation to the University of Utah’s metabolic genetics clinic for individuals with PKU. She is an Assistant Professor at the University of Utah Department of Psychiatry in the Division of Child and Adolescent Psychiatry. Dr. Bilder received a B.A. degree at Wake Forest University; an M.D degree at Vanderbilt University; and completed her Triple Board (pediatrics, general psychiatry, child and adolescent psychiatry) residency at University of Utah. She is board certified in all three specialties. Following residency, she received certification through pediatrics in Utah Leadership Education in Neurodevelopmental Disabilities. Her research interests include autism epidemiology, autism adult outcomes, and psychiatric complications of PKU.
Clinical Locations
650 Komas
Neurobehavior H.O.M.E. Program801-581-5515
Board Certification and Academic Information
| Academic Departments | Psychiatry
-
Associate Professor (Clinical) Pediatrics - Adjunct Associate Professor |
| Academic Divisions | Child Psychiatry General Pediatrics |
| Board Certification | American Board of Psychiatry & Neurology (Child & Adolescent Psychiatry) American Board of Pediatrics (Pediatrics) American Board of Psychiatry & Neurology (Psychiatry) |
Deborah Bilder, MD completed the triple board residency program (Pediatrics, General Psychiatry, Child & Adolescent Psychiatry) at the University of Utah and has attained board certified in all three specialties. Following residency, she participated in the Utah Leadership Education in Neurodevelopmental Disabilities (ULEND) as a pediatric trainee. Dr. Bilder is a clinician investigator, Assistant Professor (clinical track), and Medical Director of the Autism Diagnostic Clinic and the Neurobehavior HOME Program. Her two areas of clinical and research expertise are autism spectrum disorders and the management of psychiatric comorbidity associated with phenoketonuria (PKU). Dr. Bilder first began her research career in autism as a CDC-trained expert clinician reviewer for Utah’s autism prevalence study. She has contributed to autism research in the fields of epidemiology, adult outcomes, medical/psychiatric comorbidity, and genetics. Dr. Bilder has co-authored published manuscripts on autism, intellectual disability, and PKU-associated psychiatric disorders. She has assisted with the preparation of successful grant applications in autism adult outcome (Autism Speaks), surveillance (CDC), and genetics (NIH RO1). In regards to PKU, Dr. Bilder has participated in the NIH work group on the long-term cognitive outcomes and follow-up of adults with PKU. She also serves as a consultant to BioMarin Pharmaceutical, Inc.
Academic Locations
650 Komas
801-581-7952
Board Certification and Academic Information
| Academic Departments | Psychiatry
-
Associate Professor (Clinical) Pediatrics - Adjunct Associate Professor |
| Academic Divisions | Child Psychiatry General Pediatrics |
| Board Certification | American Board of Psychiatry & Neurology (Child & Adolescent Psychiatry) American Board of Pediatrics (Pediatrics) American Board of Psychiatry & Neurology (Psychiatry) |
Education History
| Other Training | Utah Leadership Education in Neurodevelopmental Disabilities Pediatrics Certification |
| Residency | University of Utah School of Medicine Triple Board Resident |
| Internship | University of Utah School of Medicine Triple Board Intern |
| Professional Medical | Vanderbilt University Medicine M.D. |
| Undergraduate | Wake Forest University School of Medicine German B.A. |
Selected Publications - Journal Articles
Journal Article
- Bilder DA, Kobori JA, Cohen-Pfeffer JL, Johnson EM, Jurecki ER, Grant ML (2017). Neuropsychiatric comorbidities in adults with phenylketonuria: A retrospective cohort study. Mol Genet Metab, 121(1), 1-8.
- Woodbury-Smith M, Bilder DA, Morgan J, Jerominski L, Darlington T, Dyer T, Paterson, AD, Coon, H (in press). Combined genome-wide linkage and targeted association analysis for head circumference in autism spectrum disorder families. J Neurodev Disord.
- Dickerson AS, Rahbar MH, Pearson DA, Kirby RS, Bakian AV, Bilder DA, Harrington RA, Pettygrove S, Zahorodny WM, Moy LA 3rd, Durkin M, Slay Wingate M (2017). Autism spectrum disorder reporting in lower socioeconomic neighborhoods. Autism, 21(4), 470-480.
- Dickerson AS, Rahbar MH, Bakian AV, Bilder DA, Harrington RA, Pettygrove S, Kirby RS, Durkin MS, Han I, Moy LA 3rd, Pearson DA, Wingate MS, Zahorodny WM (2016). Autism spectrum disorder prevalence and associations with air concentrations of lead, mercury, and arsenic. Environ Monit Assess, 188(7), 407.
- Autism and Developmental Disabilities Monitoring Network Surveillance Year 2012 Principal Investigators (2016). Prevalence and characteristics of autism spectrum disorder among children aged 8 years – Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2012. MMWR Surveill Summ, 65(3), 1-23.
- Viau K, Jones JL, Murtaugh MA, Gren LH, Stanford JB, Bilder DA (2016). Phone-based motivational interviewing to increase self-efficacy in individuals with phenylketonuria. Mol Genet Metab Rep, 6, 27-33.
- Wyrwich KW, Shaffer S, Gries K, Auguste P, Mooney KH, Prasad S, Bilder DA (2016). Content validity of the ADHD Rating Scale (ADHD RS-IV) and Adult ADHD Self-Report Scale (ASRS) in phenylketonuria. Journal of Inborn Errors of Metabolism and Screening, 4, 1-9.
- Ruiz LM, Damron M, Jones KB, Weedon D, Carbone PS, Bakian AV, Bilder DA (2016). Antipsychotic Use and Metabolic Monitoring in Individuals with Developmental Disabilities Served in a Medicaid Medical Home. J Autism Dev Disord, 46(6), 1887-94.
- Viau KS, Jones JL, Murtaugh MA, Gren LH, Stanford JB, Bilder DA (2016). Phone-based motivational interviewing to increase self-efficacy in individuals with phenylketonuria. Mol Genet Metab Rep, 6, 27-33.
- Bilder DA, Bakian AV, Stevenson DA, Carbone PS, Cunniff C, Goodman AB, McMahon WM, Fisher NP, Viskochil D (2016). Brief Report: The Prevalence of Neurofibromatosis Type 1 among Children with Autism Spectrum Disorder Identified by the Autism and Developmental Disabilities Monitoring Network. J Autism Dev Disord, 46(10), 3369-76.
- Bilder DA, Noel JK, Baker ER, Irish W, Chen Y, Merilainen MJ, Prasad S, Winslow BJ (2016). Systematic Review and Meta-Analysis of Neuropsychiatric Symptoms and Executive Functioning in Adults With Phenylketonuria. Dev Neuropsychol, 41(4), 245-260.
Video/Film/CD/Web/Podcast
- Bilder, D, Lainhart J (2004). "Autism Module", Utah Collaborative Medical Home Project [Web]. Utah Collaborative Medical Home Project. Available: http://medhome.med.utah.edu/diag/diagnosis.cfm?diag_id=20&.
Poster
- Bilder D (2005). "Efficacy and Financial Viability of an Integrated Model for Behavioral Health and Primary Care". Poster session presented at Future Leaders in Psychiatry Conference.